欧林生物(688319)每日收评(07-04)

Group 1 - The stock of Olin Bio (688319) has a comprehensive score of 49.71, indicating a weak performance [1] - The main cost analysis shows the following prices: current main cost at 16.28 CNY, 5-day main cost at 16.07 CNY, 20-day main cost at 16.33 CNY, and 60-day main cost at 16.09 CNY [1] - There have been no instances of the stock hitting the upper or lower limit in the past year [1] Group 2 - On July 4, 2025, the net outflow of main funds was 14.08 million CNY, accounting for -17% of the total transaction amount [2] - The stock's short-term resistance is at 16.60 CNY, while the short-term support is at 15.66 CNY [2] - The recent financial report indicates a net profit of -7,041,533.34 CNY and an operating profit of -0.07 billion CNY, with a sales gross margin of 93.43% [2][3] Group 3 - The stock is associated with sectors such as bioproducts (0.38%), biovaccines (0.30%), innovative drugs (1.18%), and the western development sector (-0.53%) [2][3] - The stock is currently experiencing unclear short-term and mid-term trends, awaiting direction from main funds [2][3]